BioVest News and Announcements
November 29, 2004
BIOVEST INTERNATIONAL APPOINTS CHIEF OPERATING OFFICEROctober 28, 2003
BIOVEST INTERNATIONAL ANNOUNCES cGMP ANTIBODY-MANUFACTURING AGREEMENT
WITH BioEOctober 16, 2003
BIOVEST TO EXPAND PRODUCTION OF NCI VACCINE IN PIVOTAL PHASE III STUDY FOR NON-HODGKINS LYMPHOMAJune 30, 2003
ACCENTIA, INC. ACQUIRES A CONTROLLING INTEREST IN BIOVEST INTERNATIONALApril 15, 2003
ACCENTIA, INC. TO ACQUIRE 81% INTEREST IN BIOVEST INTERNATIONAL, INC.August 2001
Demand for Both Cell Culture and Fermentation CapabilitiesJune 1, 2001
GENETIC ENGINEERING NEWS Current Trends and Innovations in Cell Culture (v. 21, #11, June 1, 2001)January 26, 2001
Cancer Vaccine Pioneer at NYU to Review Vaccine AdvancesDecember 11, 2000
National Cancer Institute and BioVest International Partner to Develop Vaccines for B-Cell Lymphomas
(c) 2005 BioVest International, Inc